New York Monthly Puff: NY Hits $1.69B in 2025 Sales as Licensing Challenge Proceeds

New York Cannabis Retail Market Update — March 2026

New York cannabis retail closed out March 2026 with more momentum than friction, but the friction is real. The state crossed $3.3 billion in cumulative sales since legalization, 610 licensed dispensaries are operating, and OCM projects $2.6 billion in sales by end of 2026. At the same time, a federal judge ruled in late March 2026 that a constitutional challenge to New York’s equity-based licensing framework will proceed, a $6 million grant program is targeting equity licensees, and the constraint on new store openings has shifted from licenses to real estate. The month also brought continued enforcement sweeps, a proposed library setback bill, temporary retail permit extensions, and the first formal cannabis agenda item before the Buffalo Planning Board.

If you’re in expansion mode don’t miss out on the 4 acquisition opportunities at the bottom of this message.

Top Headlines This Month

• 📊 NY posts $1.69B in 2025 sales; projects $2.6B for 2026
• 🏙️ Real estate replaces licenses as the binding constraint
• ⚖️ Federal court allows NY equity licensing challenge to proceed
• 💰 $6M equity grant program opens; awards up to $30K each
• 🏛️ Buffalo Planning Board places cannabis sales regulation on agenda

📊 Statewide: New York Cannabis Retail Posts $1.69B in 2025 Sales and Projects $2.6B in 2026

New York posted $1.69 billion in adult-use cannabis retail sales in 2025, establishing the first full-year baseline since legalization. OCM projects that figure climbs to $2.6 billion by end of 2026, supported by sales data showing nearly $250 million in the first three weeks of February alone. Cumulative sales since the December 2022 launch reached $2.97 billion as of March 5, 2026. The state also marked five years since passage of the Marihuana Regulation and Taxation Act on March 27, with Governor Hochul citing the 610 active dispensaries and 2,161 total adult-use licenses issued. Medical cannabis, by contrast, posted $95.5 million through November 2025, down 30% year-over-year from $140 million in 2024. Meanwhile, the Cannabis Control Board voted to allow existing cultivators to apply to move up one tier to increase available canopy, with those applications reviewed over the next year.

The adult-use trajectory positions the New York cannabis retail market as one of the fastest-growing state markets in the country, with OCM projecting $3.7 billion in annual sales by 2027. The simultaneous medical decline — driven in part by price sensitivity and patient attrition — is keeping pressure on a separate legislative push to repeal the state’s 3.15% medical cannabis excise tax, introduced by State Senator Jeremy Cooney. No vote on that proposal has been scheduled.

🏙️ New York City: Real Estate Now the Binding Constraint on New York Cannabis Retail Growth

Reporting from mid-March confirmed what site selectors have been flagging for months: New York’s cannabis retail bottleneck has moved from licensing to real estate. Hundreds of adult-use dispensaries are now operating, demand is strongest in New York City, and Manhattan’s buffer requirements combined with narrow storefronts are compressing available inventory. Landlords are increasingly open to cannabis tenants, but rent expectations can spike late in negotiations. Location cannibalization is creating a visible two-tier performance gap. Upstate stores face separate pressure from price competition near sovereign tribal lands. Financing frictions remain a consistent obstacle for independent retailers. A site at Gotham NYC, 3 E. Third St. in Manhattan, was cited as an example of the type of urban retail footprint drawing attention. On the advertising side, a February 2026 law bans billboard advertising by cannabis companies, and OCM is currently taking a “soft touch” enforcement approach to allow existing contracts to wind down before escalating action. Complaints are active statewide, including a documented sighting on I-490 in Rochester.

For anyone tracking New York dispensary opportunities, site control is now the variable that determines market entry timing more than any regulatory milestone. The billboard ban also creates a near-term compliance deadline for any retailer running outdoor advertising, with OCM signaling that enforcement will sharpen after the grace period ends.

⚖️ Northern District of New York: Federal Court Allows Licensing Challenge to Proceed

A federal judge in the U.S. District Court for the Northern District of New York ruled on March 25, 2026 that a constitutional challenge to the state’s cannabis licensing framework will proceed. The court rejected state regulators’ motion to dismiss claims that the equity-based licensing system — which gives priority to applicants with prior marijuana convictions under New York law — violates the U.S. Constitution’s interstate commerce protections. The ruling followed an August 2025 Second Circuit decision holding that the dormant Commerce Clause applies to cannabis licensing. No trial date has been announced.

If the challenge succeeds, the state’s Social and Economic Equity licensing priorities could be restructured. That framework currently accounts for 56% of all adult-use licenses issued, 57% going to women-owned businesses, and 51% to minority-owned businesses. A court-ordered change to those priorities would alter the competitive entry conditions for future retail applicants across the entire New York cannabis market.

💰 Statewide: $6M Equity Business Development Grant Program Announced for CAURD and SEE Licensees

The Cannabis Control Board announced the Equity Business Development Grant Program in late March 2026, a $6 million initiative targeting CAURD and supply-side Social and Economic Equity licensees. Individual awards are expected to reach up to $30,000, with approximately 190 licensees eligible. The CCB plans to complete grant administrator procurement in Q2 2026, with the application portal expected to open in Fall 2026. The same March 5 CCB session renewed 14 adult-use retail licenses under Resolution 2026-14, requiring each to provide additional Community Impact Plan information within 60 days of an OCM request. That session also approved 20 new adult-use licenses — including four standard Adult Use Retail Dispensary licenses and four Conditional Adult-Use Retail Dispensary licenses — with all new licensees barred from beginning operations until receiving written OCM compliance approval. The Senate Budget Resolution R1722, adopted in March, also extended temporary retail permit authorization for an additional 12 months.

The grant program represents non-dilutive capital for equity retailers at a stage when buildout and compliance costs are a persistent challenge. The 60-day Community Impact Plan clock for renewals and new approvals adds a defined compliance milestone that licensed retailers need to track this spring.

🏛️ Buffalo: Planning Board Places Cannabis Sales Regulation on Agenda for the First Time

The Buffalo Planning Board included “Cannabis Sales Regulation” as a formal agenda item at its March 23, 2026 meeting — the first documented appearance of cannabis retail regulation on a Buffalo municipal planning agenda. Prior to this meeting, no active dispensary licenses or cannabis retail business licenses were found in Buffalo municipal records, reflecting a currently prohibited status. The meeting ran from 4:00 PM to 5:00 PM at the OSP Conference Room. No vote outcome or ordinance text has been published as of March 30, 2026.

Buffalo is the second-largest city in New York by population and one of the few major markets where cannabis retail remains effectively absent. Any policy shift there opens a significant untapped retail footprint. Monitoring the Planning Board’s follow-up actions and any ordinance language posted to the city website is the next step to track whether this agenda item advances toward a formal opt-in decision.

💼 New York Acquisition Opportunities

Interested in learning more about these New York cannabis acquisition opportunities? Contact us directly to get started.

The Bottom Line

New York cannabis retail entered April 2026 with $3.3 billion in cumulative sales, 610 active dispensaries, and a federal court ruling allowing a constitutional challenge to proceed that could reshape who gets a license going forward. The CCB continued approving and renewing licenses at pace, $6 million in equity grants are moving toward a Fall 2026 application window, and Buffalo just put cannabis sales regulation on a planning agenda for the first time. The market is scaling — and the structural questions around licensing, real estate, and equity frameworks are scaling with it.